文献检索
文档翻译
深度研究
学术资讯

Zotero 插件

邀请有礼
套餐&价格
历史记录

应用&插件

Zotero 插件浏览器插件 Mac 客户端 Windows 客户端微信小程序

定价

高级版会员购买积分包购买API积分包

服务

文献检索文档翻译深度研究 API 文档 MCP 服务

关于我们

关于 Suppr 公司介绍联系我们用户协议隐私条款

关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究

粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

勘误：靶向CD44递送包裹于硫醇化壳聚糖中的溶瘤新城疫病毒用于宫颈癌的持续释放：一种靶向免疫治疗方法。

Corrigendum: CD44 targeted delivery of oncolytic Newcastle disease virus encapsulated in thiolated chitosan for sustained release in cervical cancer: a targeted immunotherapy approach.

作者信息

Kousar Kousain, Naseer Faiza, Abduh Maisa Siddiq, Anjum Sadia, Ahmad Tahir

机构信息

Industrial Biotechnology, Atta-Ur-Rahman School of Applied Biosciences, National University of Sciences and Technology, Islamabad, Pakistan.

Shifa College of Pharmaceutical Sciences, Shifa Tameer e Millat University, Islamabad, Pakistan.

出版信息

Front Immunol. 2024 Mar 11;15:1391710. doi: 10.3389/fimmu.2024.1391710. eCollection 2024.

DOI:10.3389/fimmu.2024.1391710

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10961717/

Abstract

[This corrects the article DOI: 10.3389/fimmu.2023.1175535.].

摘要

[本文更正了文章的数字对象标识符：10.3389/fimmu.2023.1175535。]

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e43/10961717/4b09d3c0f94f/fimmu-15-1391710-g013.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e43/10961717/899dfbdaa9a6/fimmu-15-1391710-g010.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e43/10961717/4b09d3c0f94f/fimmu-15-1391710-g013.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e43/10961717/899dfbdaa9a6/fimmu-15-1391710-g010.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e43/10961717/4b09d3c0f94f/fimmu-15-1391710-g013.jpg

相似文献

1

Corrigendum: CD44 targeted delivery of oncolytic Newcastle disease virus encapsulated in thiolated chitosan for sustained release in cervical cancer: a targeted immunotherapy approach.勘误：靶向CD44递送包裹于硫醇化壳聚糖中的溶瘤新城疫病毒用于宫颈癌的持续释放：一种靶向免疫治疗方法。

Front Immunol. 2024 Mar 11;15:1391710. doi: 10.3389/fimmu.2024.1391710. eCollection 2024.

2

CD44 targeted delivery of oncolytic Newcastle disease virus encapsulated in thiolated chitosan for sustained release in cervical cancer: a targeted immunotherapy approach.巯基化壳聚糖包载的靶向 CD44 的溶瘤新城疫病毒用于宫颈癌的持续释放：一种靶向免疫治疗方法。

Front Immunol. 2023 May 22;14:1175535. doi: 10.3389/fimmu.2023.1175535. eCollection 2023.

3

Formulation for the Targeted Delivery of a Vaccine Strain of Oncolytic Measles Virus (OMV) in Hyaluronic Acid Coated Thiolated Chitosan as a Green Nanoformulation for the Treatment of Prostate Cancer: A Viro-Immunotherapeutic Approach.基于透明质酸修饰巯基化壳聚糖的疫苗株麻疹病毒（OMV）靶向递释系统的构建及其作为一种绿色纳米制剂治疗前列腺癌的研究：一种病毒免疫治疗方法。

Int J Nanomedicine. 2023 Jan 9;18:185-205. doi: 10.2147/IJN.S386560. eCollection 2023.

4

Green synthesis of hyaluronic acid coated, thiolated chitosan nanoparticles for CD44 targeted delivery and sustained release of Cisplatin in cervical carcinoma.用于宫颈癌中CD44靶向递送和顺铂缓释的透明质酸包被、硫醇化壳聚糖纳米颗粒的绿色合成

Front Pharmacol. 2023 Jan 12;13:1073004. doi: 10.3389/fphar.2022.1073004. eCollection 2022.

5

Formulation for the Targeted Delivery of a Vaccine Strain of Oncolytic Measles Virus (OMV) in Hyaluronic Acid Coated Thiolated Chitosan as a Green Nanoformulation for the Treatment of Prostate Cancer: A Viro-Immunotherapeutic Approach [Retraction].用于靶向递送溶瘤麻疹病毒（OMV）疫苗株的制剂，以透明质酸包被的硫醇化壳聚糖作为治疗前列腺癌的绿色纳米制剂：一种病毒免疫治疗方法[撤回]

Int J Nanomedicine. 2024 Jun 12;19:5719-5720. doi: 10.2147/IJN.S482137. eCollection 2024.

6

O-2'-hydroxypropyltrimethyl ammonium chloride chitosan nanoparticles for the delivery of live Newcastle disease vaccine.O-2'-羟丙基三甲基氯化铵壳聚糖纳米粒递呈活新城疫疫苗。

Carbohydr Polym. 2015 Oct 5;130:280-9. doi: 10.1016/j.carbpol.2015.05.008. Epub 2015 May 16.

7

Corrigendum: Advances in oncolytic herpes simplex virus and adenovirus therapy for recurrent glioma.勘误：复发性胶质瘤的溶瘤单纯疱疹病毒和腺病毒治疗进展

Front Immunol. 2023 Dec 19;14:1352909. doi: 10.3389/fimmu.2023.1352909. eCollection 2023.

8

Anticancer Analysis of CD44 Targeted Cyclosporine Loaded Thiolated Chitosan Nanoformulations for Sustained Release in Triple-Negative Breast Cancer [Retraction].用于三阴性乳腺癌持续释放的 CD44 靶向负载环孢素的硫醇化壳聚糖纳米制剂的抗癌分析 [撤回]

Int J Nanomedicine. 2024 Jun 11;19:5705-5706. doi: 10.2147/IJN.S482136. eCollection 2024.

9

Corrigendum: Targeted proteomics-determined multi-biomarker profiles developed classifier for prognosis and immunotherapy responses of advanced cervical cancer.勘误：靶向蛋白质组学确定的多生物标志物谱为晚期宫颈癌的预后和免疫治疗反应开发了分类器。

Front Immunol. 2024 Jul 2;15:1437676. doi: 10.3389/fimmu.2024.1437676. eCollection 2024.

10

Corrigendum: Oncolytic Adenovirus-A Nova for Gene-Targeted Oncolytic Viral Therapy in HCC.勘误：溶瘤腺病毒-A新星用于肝癌的基因靶向溶瘤病毒治疗。

Front Oncol. 2020 May 5;10:701. doi: 10.3389/fonc.2020.00701. eCollection 2020.